A randomized crossover clinical study showing that methylphenidate-SODAS improves attention-deficit/hyperactivity disorder symptoms in adolescents with substance use disorder.
about
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)Methylphenidate for attention-deficit/hyperactivity disorder in children and adolescents: Cochrane systematic review with meta-analyses and trial sequential analyses of randomised clinical trialsMethylphenidate treatment in adolescent rats with an attention deficit/hyperactivity disorder phenotype: cocaine addiction vulnerability and dopamine transporter function.Randomized, controlled trial of atomoxetine for attention-deficit/hyperactivity disorder in adolescents with substance use disorder.Pharmacological Treatment of ADHD in Addicted Patients: What Does the Literature Tell Us?An Open Trial of Sustained Release Bupropion for Attention-Deficit/Hyperactivity Disorder in Adults with ADHD plus Substance Use Disorders.Treatments for Adolescents With Comorbid ADHD and Substance Use Disorder: A Systematic Review.Substance-use disorders in adolescents and adults with ADHD: focus on treatment.Pharmacotherapy for Substance Use Disorders in Youths.Pharmacological treatment of attention deficit hyperactivity disorder with co-morbid drug dependence.A multicenter, open-label trial to evaluate the quality of life in adults with ADHD treated with long-acting methylphenidate (OROS MPH): Concerta Quality of Life (CONQoL) study.
P2860
Q22061981-2EDAE5AD-5C42-4B3E-B091-1C7DF0B7AF3FQ27007856-2D86F2A3-5703-4807-AB4F-50D43E0016E7Q30498578-CE5D6663-A8F3-4A74-A67E-26F98C1DAD50Q33876388-266D3C9C-5A91-4127-851E-F77C48586640Q33919950-D5F43CA2-0686-41F0-BE58-AD39328F3CC9Q35878684-8C04D133-3723-4B0F-B477-A838994A1260Q36338808-949DDEE5-8E39-4B68-90CF-99A91888967AQ36344412-CAA3FFEB-90B8-45AF-B74F-4E9D5F8E844FQ37574339-20E906A6-7892-4F2E-B31A-04A60DFA487CQ38241724-51F5D787-AEEF-47A9-A9E3-416B6AB7FBFDQ42636359-E15E2EF7-89ED-4E28-B415-24C49310B58C
P2860
A randomized crossover clinical study showing that methylphenidate-SODAS improves attention-deficit/hyperactivity disorder symptoms in adolescents with substance use disorder.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
A randomized crossover clinica ...... s with substance use disorder.
@en
A randomized crossover clinica ...... s with substance use disorder.
@nl
type
label
A randomized crossover clinica ...... s with substance use disorder.
@en
A randomized crossover clinica ...... s with substance use disorder.
@nl
prefLabel
A randomized crossover clinica ...... s with substance use disorder.
@en
A randomized crossover clinica ...... s with substance use disorder.
@nl
P2093
P2860
P1476
A randomized crossover clinica ...... s with substance use disorder.
@en
P2093
C M Szobot
F Pechansky
O Bukstein
T Schaefer
P2860
P304
P356
10.1590/S0100-879X2008005000011
P407
P577
2008-02-20T00:00:00Z